A director at Elisa Oyj sold 10,000 shares at 45.730EUR and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Elisa has reported a slightly mixed set of results – SR has missed by -1.6%, but EBITDA is +0.9% ahead. LFL y/y EBITDA trends are better, but LFL y/y SR trends are slower, and that’s the rub: Elisa can’t seemingly grow EBITDA and SR at the same time, or more importantly EBITDA at faster rate than SR, but with good SR growth. Until that changes, or it beats expectations, it is unlikely to materially re-rate in our view, hence the Neutral rating.
We forecast a fairly solid Q1 (results due at 07:30 CET on 17 April), with stabilised churn from the elevated levels in Q4. We expect a slight slowdown of YOY MSR growth versus Q4 and solid 10% organic growth for the international software business. We reiterate our HOLD, but have raised our target price to EUR47 (45).
Elisa held their CMD in London yesterday with new guidance to 2027. Elisa has lifted revenue and EBITDA CAGRs (to 4% from 2%). Although there clearly remains a lack of operational leverage, the new higher growth outlook is a touch better than consensus expectation.
Elisa has reported a slightly mixed set of results - reported service revenue growth has reaccelerated and is now back in the MSD range (albeit +2.5% y/y from +0.5% y/y ex M&A), but ex M&A EBITDA growth has slowed to +2.2% y/y from +2.9% y/y, and EBITDA is c1% light vs consensus expectations.
We forecast muted revenue growth in Q4, in line with consensus. However, IDS should show solid organic growth. Guidance is likely to be cautious. We prefer Telia and Tele2 over Elisa, and reiterate our HOLD. We have lowered our target price to EUR47 (48).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.